Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MHRA Consults On Applying Quality By Design Principles To Monographs

Executive Summary

The proposal by the UK regulator builds on a case study which showed that AQbD processes can add value to pharmacopoeial method development.

You may also be interested in...



Industry Urged To Use ICH Q12 Protocols To Ease Post-Approval Changes For Analytical Methods

Post-approval change management protocols could go a long way toward smoothing global rollout of analytical method changes, ICH Q12 expert says.

Takeda Test Drives EMA’s Parallel Review Route For EU And Non-EU Markets

A new evaluation route that the European Medicines Agency launched last year came at the right time for Takeda’s dengue vaccine candidate. 

EMA’s Revised Guide On Additional Risk Minimization ‘Overly Detailed’

Executive Summary: The European pharma industry federation believes the advice provided in the updated draft EU guideline on additional risk minimization measures is far too detailed, resulting in a lack of focus, information overlap and confusion.

Topics

UsernamePublicRestriction

Register

PS125416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel